November 16, 2022 Joseph Burleson, Michele Korver and Dan Boneh Editor’s note: Below is the full text of the paper “Privacy-Protecting Regulatory...

TOKYO, Nov 16, 2022 - (JCN Newswire) - Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of medac Gesellschaft fur klinische Spezialpraparate mbH announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg syringe 0.15mL, 10mg syringe 0.20mL, 12.5mg syringe 0.25mL and 15mg syringe 0.30mL" (methotrexate, "MTX") in Japan with the indication of rheumatoid arthritis. nippon medac obtained the manufacturing and marketing approval of Japan's first self-administrable subcutaneous injection formulation of MTX, a first line option for the treatment of rheumatoid arthritis, on September 26, 2022. The product is published to Japan's National Health Insurance Drug Price List, today.
The approval of Metoject in Japan is based on the results of a Phase III clinical trial (MC-MTX.17/RA) conducted in Japan by nippon medac to compare the efficacy and safety of Metoject with that of oral MTX, which consisted of a double-blind phase and an extension phase. Based on the license agreement signed by Eisai and medac GmbH in May 2019, nippon medac will hold the marketing authorization of Metoject, while Eisai will be responsible for product distribution of Metoject in Japan.

"Eisai has established a solid franchise and has extensive sales experience in the rheumatoid arthritis area in Japan. By adding Metoject to Eisai's product lineup, we are now able to contribute to rheumatoid arthritis patients in a wide range of stages from the early stages of treatment," said Terushige Iike, Senior Vice President of Eisai and President of Eisai Japan. "We are committed to making further contributions to address the diversified needs of, and increase the benefits provided to, rheumatoid arthritis patients."

"Metoject is the first drug for which nippon medac obtained its manufacturing and marketing approval in Japan. It is also the first self-administrable MTX subcutaneous injection formulation for rheumatoid arthritis in Japan," said Hirohisa Iriyama, Representative Director and President of nippon medac. "Although the drug is already widely used overseas, Eisai, which has extensive experience in this area, has been entrusted with the marketing of the drug in Japan, where there are an estimated 700,000 to 800,000 rheumatoid arthritis patients1, allowing us to bring the drug to them as a new treatment option. Nippon medac will continue to make further contributions in this area."

For more information, visit www.eisai.com/news/2022/news202278.html.

Media Inquiries:

Eisai Co., Ltd.
Public Relations Department
TEL: +81-(0)3-3817-5120

nippon medac Co., Ltd.
Ueno
TEL: +81-(0)3-6661-6270


Copyright 2022 JCN Newswire. All rights reserved. www.jcnnewswire.comEisai Co., Ltd. and nippon medac Co., Ltd. announced today that they have launched the anti-rheumatic agent "Metoject Subcutaneous Injection 7.5mg syringe 0.15mL, 10mg syringe 0.20mL, 12.5mg syringe 0.25mL and 15mg syringe 0.30mL" (methotrexate, "MTX") in Japan.

By Cornelius Christian   FTX, once the third largest crypto exchange by trading volume, collapsed over the past week as its native token, FTT, lost over 80 percent of its value. The firm has now filed for Chapter 11 bankruptcy protection, and its collapse could impact the entire crypto sector, said Ran Neuner, Host and […]

The post FTX collapse could mean ‘cascade’ of failures in crypto sector appeared first on Fintech News.

11 November 2022: A multi-store, e-commerce start-up and an energy drink brand were among the winners at this year’s SAVCA Industry Awards, hosted by...

In a sample of indistinguishable photons, just how indistinguishable are they? An international team of scientists has now answered this question...

The latest issue of TapTools’ Weekly newsletter talked about Grayscale Smart Contract Platform Ex-Ethereum Fund (GSCPxE), which gives U.S. investors exposure to multiple major cryptocurrencies in the form of a security that they can own in a tax-sheltered account. Grayscale Investments, which is one of the world’s largest digital asset managers, launched this fund on 22 […]

AdvertisementThe United States and South Korea will begin their biggest combined military training in years next week in the face of an increasingly aggressive...

First casino The first casino opened its doors to gamblers in 1863 in Monaco. In Italian, "casino" means country house. Such a country house, in...

On 12 December, 2021, AeroNewsX officially announced its closure and subsequent suspension of operations on its social media pages – comprising Instagram, Twitter and...

Ethereum is the leading blockchain app platform that was proposed in 2013 by Vitalik Buterin and went live on July 30, 2015. There are...